Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
Queensland Health
Mallinckrodt
Cipla
US Department of Justice
Covington
Cerilliant

Generated: January 23, 2019

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has seventy-one approved drugs.

There are two tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc
US Patents:0
Tradenames:56
Ingredients:54
NDAs:71

Drugs and US Patents for Actavis Labs Fl Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride FOR SUSPENSION, EXTENDED RELEASE;ORAL 206049-001 May 17, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc LEVETIRACETAM levetiracetam TABLET;ORAL 077408-003 Mar 2, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 076172-001 Jun 16, 2004 AB1 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc BUDESONIDE budesonide TABLET, EXTENDED RELEASE;ORAL 205457-001 Jul 3, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 091093-002 Sep 12, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 203755-002 Aug 1, 2016 AB3 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Labs Fl Inc METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 077298-001 Apr 15, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
AstraZeneca
Boehringer Ingelheim
Chubb
Argus Health
US Department of Justice
Federal Trade Commission
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.